Aug 21, 2009 by Brian Orelli, PhDForget Swine Flu: The Big Money Is HereVaccines are pharma's, and possibly investors', best friend.
Aug 20, 2009 by Brian Orelli, PhDThe Health Reform Witch HuntCongress warms up the tar and feathers for health-insurance execs.
Aug 19, 2009 by Brian Orelli, PhDAmgen's Climbing Up the LadderPositive trial data should help sales.
Aug 19, 2009 by Brian Orelli, PhDThem's the Breaks for LillyThe drugmaker cuts its losses after a disappointing trial on an osteoporosis drug.
Aug 18, 2009 by Brian Orelli, PhDMackey and Health Care -- What the Heck?Whole Foods CEO John Mackey is back in the news with his own proposal.
Aug 14, 2009 by Brian Orelli, PhDAmgen Close to Scoring BigAmgen gets good-enough results from a FDA panel.
Aug 14, 2009 by Brian Orelli, PhDThe Real King of the Drug PushersKing Pharma is first up with a tamper-resistant morphine tablet.
Aug 13, 2009 by Brian Orelli, PhDWuXi: Making Money Both WaysCost-cutting and revenue growth make WuXi a looker for the year.
Aug 12, 2009 by Brian Orelli, PhDThe Next Big Thing Is Not Right in Front of YouBut one Fool things he knows where it is.
Aug 10, 2009 by Brian Orelli, PhDThis Volatile Stock Has Growth PotentialChina is scary. AOB? Scarier.
Aug 7, 2009 by Brian Orelli, PhDThe Wrong Way to Invest in the Right StocksExchange-traded funds don't work for this industry.
Aug 7, 2009 by Brian Orelli, PhDA Billion-Dollar Lovers' QuarrelA nasty breakup over a potential blockbuster.
Aug 4, 2009 by Brian Orelli, PhDShockingly Cheap and Destined to Stay That Way?Humana has a nice quarter, but it's priced based on the uncertain future.
